Scpharmaceuticals Inc (SCPH) — Strategic Asset Allocation Index
Scpharmaceuticals Inc (SCPH) has a Strategic Asset Allocation Index of 0.6% as of June 2023. Strategic assets (PP&E of $408.00K plus long-term investments of $-) total $408.00K, measured against net assets of $63.43 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Scpharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Scpharmaceuticals Inc Strategic Asset Allocation Index (2017–2022)
This chart shows how Scpharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 0.6%, representing strategic assets of $408.00K against net assets of $63.43 Million USD.
Annual Strategic Asset Allocation Index for Scpharmaceuticals Inc (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Scpharmaceuticals Inc from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Scpharmaceuticals Inc (SCPH) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $54.00K | $54.00K | $- | $72.43 Million | ▼ 0.0 pp |
| 2021 | 0.1% | $69.00K | $69.00K | $- | $56.47 Million | ▼ -1.0 pp |
| 2020 | 1.1% | $908.00K | $908.00K | $- | $82.17 Million | ▼ -1.4 pp |
| 2019 | 2.5% | $1.31 Million | $1.31 Million | $- | $51.37 Million | ▲ +0.4 pp |
| 2018 | 2.1% | $1.67 Million | $1.67 Million | $- | $78.74 Million | ▲ +0.3 pp |
| 2017 | 1.9% | $1.98 Million | $1.98 Million | $- | $106.00 Million | — |